FRAGRANCE Trial (Femara Reanalysed Through Genomics for Response Assessment, Calibration and Empowerment)

Trial Profile

FRAGRANCE Trial (Femara Reanalysed Through Genomics for Response Assessment, Calibration and Empowerment)

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jan 2015

At a glance

  • Drugs Letrozole (Primary)
  • Indications Breast cancer
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms FRAGRANCE
  • Most Recent Events

    • 14 Mar 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 14 Mar 2013 Planned end date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 08 Jun 2012 Planned End Date changed from 1 Dec 2007 to 1 Dec 2012, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top